Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.11.31 (
AMP-activated protein kinase
)
13,065
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Muscle contractions activate protein kinases, leading to signal transduction. We hypothesized that kinase activation would be influenced by mitochondrial content, as well as by contractile activity-induced increases in muscle O(2) consumption (Vo(2)). Kinase phosphorylation in high-oxidative red and low-oxidative white tibialis anterior (TA) muscle (
RTA
and WTA, respectively) with 2.5-fold differences in mitochondrial content were compared. Stimulation of the TA muscle elicited large increases in Vo(2) (3- to 6-fold and 4- to 60-fold above resting levels in WTA and
RTA
, respectively). At rest,
AMP-activated protein kinase
(
AMPK
), p38, p42, and p44 activation were nearly twofold greater in WTA than in
RTA
, suggesting an inverse relationship between mitochondrial content and kinase activation in resting muscle. During contractions, similar degrees of phosphorylation in
RTA
and WTA were evident as a function of Vo(2) for p38 and p42. During increases in Vo(2) up to sixfold above rest, greater responses were observed in
RTA
than in WTA for
AMPK
and p44, whereas Akt activation was greater in WTA. In
RTA
, elevations in Vo(2) elicited increases in
AMPK
and p44 activation, whereas Akt, p38, and p42 were less sensitive to increments in Vo(2). Reactive oxygen species (ROS) production was greater in mitochondria from white muscle, but when it was calculated in the context of the whole muscle, ROS production was twofold greater in red than in white myofibers. Thus mitochondrial content influences ROS production and is inversely related to kinase activation in resting muscle. During contractions, kinases are differentially sensitive to contraction-induced increments in Vo(2), suggesting that muscle mitochondrial content is important, but it is not the sole determinant of kinase activation during exercise of different intensities.
...
PMID:Kinase-specific responsiveness to incremental contractile activity in skeletal muscle with low and high mitochondrial content. 1849 78
The vacuolar H(+)-ATPase (V-ATPase) mediates ATP-driven H(+) transport across membranes. This pump is present at the apical membrane of kidney proximal tubule cells and intercalated cells. Defects in the V-ATPase and in proximal tubule function can cause
renal tubular acidosis
. We examined the role of protein kinase A (PKA) and
AMP-activated protein kinase
(
AMPK
) in the regulation of the V-ATPase in the proximal tubule as these two kinases coregulate the V-ATPase in the collecting duct. As the proximal tubule V-ATPases have different subunit compositions from other nephron segments, we postulated that V-ATPase regulation in the proximal tubule could differ from other kidney tubule segments. Immunofluorescence labeling of rat ex vivo kidney slices revealed that the V-ATPase was present in the proximal tubule both at the apical pole, colocalizing with the brush-border marker wheat germ agglutinin, and in the cytosol when slices were incubated in buffer alone. When slices were incubated with a cAMP analog and a phosphodiesterase inhibitor, the V-ATPase accumulated at the apical pole of S3 segment cells. These PKA activators also increased V-ATPase apical membrane expression as well as the rate of V-ATPase-dependent extracellular acidification in S3 cell monolayers relative to untreated cells. However, the
AMPK
activator AICAR decreased PKA-induced V-ATPase apical accumulation in proximal tubules of kidney slices and decreased V-ATPase activity in S3 cell monolayers. Our results suggest that in proximal tubule the V-ATPase subcellular localization and activity are acutely coregulated via PKA downstream of hormonal signals and via
AMPK
downstream of metabolic stress.
...
PMID:Regulation of proximal tubule vacuolar H(+)-ATPase by PKA and AMP-activated protein kinase. 2455 31